ABSTRACT
INTRODUCTION: Chronic stress and burnout are highly prevalent among academically trained healthcare professionals, negatively affecting their well-being and capacity to engage in their work. Resilience to stress develops early in one's career path, hence offering resilience training to university students in these professions is one approach to fostering well-being and mental health. The aim of this study is to assess whether offering mindfulness-based resilience training to university students in healthcare professions reduces their perceived chronic stress. METHODS AND ANALYSIS: The study has a hybrid design combining a longitudinal observational cohort with a nested randomized controlled trial (RCT) with sequential multiple assignment and multistage adaptive interventions while taking participants' preferences into account. All students in healthcare related programmes at the Erasmus University Rotterdam are invited to participate. Within the observational cohort, students with a score of 14 or higher on the Perceived Stress Scale (PSS) are invited to take part in the RCT (n = 706). Eligible participants are randomized to control or active intervention in a ratio of 1:6. Those randomized to the control group and non-randomized participants in the cohort receive passive web-based psychoeducation about chronic stress and burnout through referral to specific websites. Participants randomized to the intervention group receive one of 8 active mindfulness-based interventions. They select a rank order of 4 preferred interventions and are randomized across these with equal probability. Non-response to the intervention is followed by sequential randomized assignment to another intervention, for a total maximum of 3 sequential interventions. All participants receive questionnaires at baseline, before and after each 8-week intervention period, and at 1- and 2-year follow-up. The primary outcome is perceived chronic stress measured with the PSS. Secondary outcomes include mental well-being, burnout, quality of life, healthcare utilization, drug use, bodyweight, mental and physical stress-related symptoms, resilience, and study progress. ETHICS AND REGISTRATION: Approval from the Medical Ethics Review Committee was obtained under protocol number MEC-2018-1645. The trial is registered in the Netherlands National Trial Register by registration number NL7623, 22/03/2019, https://www.trialregister.nl/.
Subject(s)
Mindfulness , Humans , Mindfulness/methods , Students/psychology , Universities , Mental Health , Cohort Studies , Randomized Controlled Trials as Topic , Observational Studies as TopicABSTRACT
Diagnostic criteria for eating disorders (ED) remain largely based on clinical presentations, but do not capture the full range of behaviours in the population. We aimed to derive an empirically based ED behaviour classification using behavioural and body mass index (BMI) indicators at three time-points in adolescence, and to validate classes investigating prospective associations with adverse outcomes. Adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) provided data on ED at age 14 (n = 6615), 16 (n = 5888), and 18 years (n = 5100), and had weight and height measured. Psychological and behavioural outcomes were assessed at 15.5/16 and 17.5/18 years. We fit gender- and age-stratified latent class models, and employed logistic regression to investigate associations between classes and later outcomes. One asymptomatic and two symptomatic (largely representing higher and lower frequency ED behaviours) classes were observed at each time-point, although their relative prevalence varied by age and gender. The majority of girls in symptomatic classes remained symptomatic at subsequent assessments. Girls in symptomatic classes had higher odds of subsequent anxiety and depressive disorders, binge drinking, drug use, and deliberate self-harm. Data analyses were underpowered amongst boys. The presence of two symptomatic classes (characterised by different ED behaviour frequency) and their prospective association with adverse outcomes suggest a need to refine diagnostic thresholds based on empirical data. Despite some instability of classes, particularly in mid-adolescence, evidence that half of girls in symptomatic classes remained symptomatic suggests persistence of ED behaviours in adolescence, and highlights a need for early identification to reduce chronicity.
Subject(s)
Adolescent Behavior/psychology , Feeding and Eating Disorders/psychology , Adolescent , Anxiety Disorders/psychology , Body Mass Index , Body Weight , Child , Feeding and Eating Disorders/classification , Female , Humans , Logistic Models , Longitudinal Studies , Male , Parents , Prospective Studies , Self-Injurious Behavior/psychology , Substance-Related Disorders/psychologyABSTRACT
Despite the magnitude and consistency of risk estimates in the peer-reviewed literature linking firearm availability and suicide, inferring causality has been questioned on the theoretical basis that existing studies may have failed to account for the possibility that members of households with firearms differ from members of households without firearms in important ways related to suicide risk. The current bias analysis directly addresses this concern by describing the salient characteristics that such an unmeasured confounder would need to possess in order to yield the associations between firearm availability and suicide observed in the literature when, in fact, the causal effect is null. Four US studies, published between 1992 and 2003, met our eligibility criteria. We find that any such unmeasured confounder would need to possess an untenable combination of characteristics, such as being not only 1) as potent a suicide risk factor as the psychiatric disorders most tightly linked to suicide (e.g., major depressive and substance use disorders) but also 2) an order of magnitude more imbalanced across households with versus without firearms than is any known risk factor. No such confounder has been found or even suggested. The current study strongly suggests that unmeasured confounding alone is unlikely to explain the association between firearms and suicide.
Subject(s)
Firearms/statistics & numerical data , Suicide/statistics & numerical data , Bias , Humans , Risk Factors , Suicide/psychologyABSTRACT
OBJECTIVE: This study evaluated the hypothesis that protein concentration and mitochondrial content in gastrocnemius biopsies from patients with peripheral arterial disease (PAD) predict mortality rates. BACKGROUND: PAD patients experience advancing myopathy characterized by mitochondrial dysfunction, myofiber degradation, and fibrosis in their ischemic legs, along with increased mortality rates. METHODS: Samples from the gastrocnemius of PAD patients were used for all analyses. Protein concentration was normalized to muscle wet weight, and citrate synthase activity (standard measure of mitochondrial content in cells) was normalized to muscle wet weight and protein concentration. Protein and citrate synthase data were grouped into tertiles and 5-year, all-cause mortality for each tertile was determined with Kaplan-Meier curves and compared by the modified Peto-Peto test. A Cox-regression model for each variable controlled for the effects of clinical characteristics. RESULTS: Of the 187 study participants, 46 died during a mean follow-up of 23.0 months. Five-year mortality rate was highest for patients in the lowest tertile of protein concentration. Mortality was lowest for patients in the middle tertile of citrate synthase activity when normalized to either muscle wet weight or protein concentration. The mortality hazard ratios (HRs) from the Cox analysis were statistically significant for protein concentration normalized to muscle wet weight (lowest vs middle tertile; HR = 2.93; P = 0.008) and citrate synthase normalized to protein concentration (lowest vs middle tertile; HR = 4.68; P = 0.003; and lowest vs highest tertile; HR = 2.36; P = 0.027). CONCLUSIONS: Survival analysis of a contemporaneous population of PAD patients identifies protein and mitochondrial content of their gastrocnemius as predictors of mortality rate.
Subject(s)
Mitochondria/metabolism , Muscle Proteins/metabolism , Muscle, Skeletal/metabolism , Muscular Diseases/metabolism , Peripheral Arterial Disease/metabolism , Peripheral Arterial Disease/mortality , Adolescent , Adult , Biopsy , Child , Female , Humans , Iowa , Leg/blood supply , Male , Middle Aged , Muscular Diseases/mortality , Nebraska , Predictive Value of Tests , Survival RateABSTRACT
OBJECTIVES: We aimed to describe and report the initial validity of a newly developed structured interview for sleep disorders (Diagnostic Interview for Sleep Patterns and Disorders [DISP]) administered by trained lay interviewers. METHODS: A total of 225 patients with various sleep disorders were recruited from two nationally recognized sleep centers in the United States. The International Classification of Sleep Disorders, second edition (ICSD-2) criteria, were used to classify sleep disorders (e.g., delayed sleep phase disorder, hypersomnia, narcolepsy with cataplexy [NC], restless legs syndrome [RLS], periodic limb movement disorder [PLMD], insomnia, rapid eye movement sleep behavior disorder [RBD], and obstructive sleep apnea [OSA]). Interview diagnoses were compared with final diagnoses by sleep specialists (reference diagnosis based on clinical history, examination, and polysomnography [PSG] when indicated). RESULTS: DISP diagnoses had fair to substantial concordance with clinician diagnoses for various sleep disorders, with area under the receiver operator characteristic curves (AUC) ranging from 0.65 to 0.84. Participants classified by the clinician as having a sleep disorder were moderately well-detected (sensitivity ranging from 0.50 for RBD disorder to 0.87 for insomnia). Substantial specificity (>0.8) also was seen for five of the eight sleep disorders (i.e., delayed sleep phase, hypersomnia, NC, PLMD, and RBD). Interviews were more likely than clinicians to detect disorders secondary to the primary sleep problem. CONCLUSIONS: The DISP provides an important tool for the detection of a wide range of sleep disorders in clinical settings and is particularly valuable in the detection of secondary disorders that were not the primary referral diagnosis.
Subject(s)
Interview, Psychological/methods , Sleep Wake Disorders/diagnosis , Adult , Aged , Aged, 80 and over , Female , Humans , Interview, Psychological/standards , Male , Middle Aged , Reproducibility of Results , Sleep , Young AdultABSTRACT
BACKGROUND: The US Food and Drug Administration's meta-analyses of placebo-controlled antidepressant trials found approximately twice the rate of suicidal behaviors among children and adults aged 24 years and younger who were randomized to receive antidepressant medication than among those who were randomized to placebo. Rates of suicidal behavior were similar for subjects aged 25-64 years whether they received antidepressants or placebo, and subjects aged 65 years or older randomized to antidepressants were found to have lower rates of suicidal behavior. The age-stratified FDA meta-analyses did not have adequate power to investigate rates of suicidal behaviors by antidepressant drug class. OBJECTIVE: Our objective was to assess the risk of deliberate self-harm associated with the two most commonly prescribed classes of antidepressant agents. DESIGN: Propensity score matched cohort study of incident users of antidepressant agents. SETTING: Population-based healthcare utilization data of US residents. PATIENTS: US residents aged 10-64 years with a recorded diagnosis of depression who initiated use of selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) between 1 January 1998 and 31 December 2010. MAIN OUTCOME MEASURES: ICD-9 external cause of injury codes E950.x-E958.x (deliberate self-harm). RESULTS: A total of 102,647 patients aged between 10 and 24 years, and 338,021 aged between 25 and 64 years, initiated therapy with antidepressants. Among 10-24 year olds, prior to propensity score matching, 75,675 initiated therapy with SSRIs and 5,344 initiated SNRIs. After matching, there were 5,344 SNRI users and 10,688 SSRI users. Among the older cohort, 36,037 SNRI users were matched to 72,028 SSRI users (from an unmatched cohort of 225,952 SSRI initiators). Regardless of age cohort, patients initiating SSRIs and patients initiating SNRIs had similar rates of deliberate self-harm. Restriction to patients with no antidepressant use in the past 3 years did not alter our findings. CONCLUSIONS: Our findings of similar rates of deliberate self-harm for depressed patients who initiate treatment with either an SSRI or an SNRI suggests that physicians who have decided that their patients would benefit from initiating antidepressant therapy need not weigh differential suicide risk when deciding which class of antidepressant to prescribe.
Subject(s)
Adrenergic Uptake Inhibitors/adverse effects , Antidepressive Agents/adverse effects , Selective Serotonin Reuptake Inhibitors/adverse effects , Self-Injurious Behavior/epidemiology , Suicide/statistics & numerical data , Adolescent , Adrenergic Uptake Inhibitors/therapeutic use , Adult , Age Factors , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Child , Cohort Studies , Depressive Disorder/drug therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Propensity Score , Risk , Risk Assessment , Self-Injurious Behavior/etiology , Selective Serotonin Reuptake Inhibitors/therapeutic use , United States/epidemiology , Young AdultABSTRACT
OBJECTIVE: Anorexia nervosa (AN) and bulimia nervosa (BN) are marked by longitudinal symptom fluctuations. DSM-IV-TR does not address how to classify eating disorder (ED) presentations in individuals who no longer meet full criteria for these disorders. To consider this issue, we examined subthreshold presentations in women with initial diagnoses of AN and BN. METHOD: A total of 246 women with AN or BN were followed for a median of 9 years; weekly symptom data were collected at frequent intervals using the Longitudinal Interval Follow-up Evaluation of Eating Disorders (LIFE-EAT-II). Outcomes were ED presentations that were subthreshold for 3 months, including those narrowly missing full criteria for AN or BN, along with binge eating disorder (BED) and purging disorder. RESULTS: During follow-up, most women (77.6%) experienced a subthreshold presentation. Subthreshold presentation was related to intake diagnosis (Wald chi2=8.065, df=2, p=0.018). Individuals with AN most often developed subthreshold presentations resembling AN; those with BN were more likely to develop subthreshold BN. Purging disorder was experienced by half of those with BN and one-quarter of those with AN binge/purge type (ANBP); BED occurred in 20% with BN. Transition from AN or BN to most subthreshold types was associated with improved psychosocial functioning (p<0.001). CONCLUSIONS: Subthreshold presentations in women with lifetime AN and BN were common, resembled the initial diagnosis, and were associated with modest improvements in psychosocial functioning. For most with lifetime AN and BN, subthreshold presentations seem to represent part of the course of illness and to fit within the original AN or BN diagnosis.
Subject(s)
Anorexia/classification , Bulimia Nervosa/classification , Diagnostic and Statistical Manual of Mental Disorders , Feeding and Eating Disorders/classification , Anorexia/diagnosis , Anorexia/psychology , Bulimia Nervosa/diagnosis , Bulimia Nervosa/psychology , Chi-Square Distribution , Feeding and Eating Disorders/diagnosis , Feeding and Eating Disorders/psychology , Female , Humans , Interviews as Topic , Linear Models , Longitudinal Studies , Markov Chains , Psychology , Social Adjustment , Young AdultSubject(s)
Arthroplasty, Replacement, Knee/history , Knee Prosthesis/history , Adult , Age Factors , Aged , Arthroplasty, Replacement, Knee/methods , Body Height , Female , Hematoma/etiology , Hematoma/history , History, 20th Century , Humans , Locomotion , Male , Movement , Postoperative Complications , Prosthesis Design/history , Thrombophlebitis/etiology , Thrombophlebitis/history , Wound Healing/physiologyABSTRACT
BACKGROUND: Phosphorothioate oligonucleotides, in general, possess properties that could be utilized in the development of therapeutic heavy metal chelators. METHODS: Iron excretion was measured in 16 patients participating in studies to test the safety of OL(1)p53, a 20-mer phosphorothioate oligonucleotide complementary to p53 mRNA. Patients were given OL(1)p53 at doses of 0.05 to 0.25 mg/kg/h for 10 days by continuous intravenous infusion. Urine was collected during the study and analyzed for iron, copper, cadmium, and zinc. RESULTS: We found that phosphorothioate oligonucleotides have a high affinity for iron as well as several other clinically relevant toxic metals. Analysis of patient urine following administration of OL(1)p53 reveals a 7.5-fold increase in iron excretion at low doses (0.05 mg/kg/h). CONCLUSIONS: Phosphorothioate oligonucleotides may have therapeutic potential as heavy metal chelators. Low doses of phosphorothioate oligonucleotide facilitated the excretion of iron. Renal clearance of iron-phosphorothioate oligonucleotide complexes most likely involves secretion into proximal tubules.
Subject(s)
Iron Chelating Agents , Iron/urine , Leukemia, Myeloid, Acute/drug therapy , Myelodysplastic Syndromes/drug therapy , Oligodeoxyribonucleotides, Antisense/pharmacokinetics , Thionucleotides/pharmacokinetics , Cadmium/urine , Chelating Agents , Copper/urine , Dose-Response Relationship, Drug , Erythrocyte Count , Humans , Infusions, Intravenous , Leukemia, Myeloid, Acute/urine , Male , Metabolic Clearance Rate , Middle Aged , Myelodysplastic Syndromes/blood , Myelodysplastic Syndromes/urine , Oligodeoxyribonucleotides, Antisense/therapeutic use , Oligodeoxyribonucleotides, Antisense/urine , RNA, Messenger/antagonists & inhibitors , Spectrophotometry, Atomic , Thionucleotides/therapeutic use , Thionucleotides/urine , Tumor Suppressor Protein p53/antagonists & inhibitors , Tumor Suppressor Protein p53/genetics , Zinc/urineABSTRACT
Previous research has indicated that oxidants, antioxidants and the intracellular redox state regulate the activities of a variety of protein tyrosine kinases, protein tyrosine phosphatases, phospholipases and transcription factors. In order to explore the redox regulation of the serine/threonine phosphatase calcineurin, we have investigated the effects of a variety of oxidants and antioxidants on calcineurin phosphatase activity in vitro. The oxidants hydrogen peroxide, superoxide and glutathione disulfide inhibited the phosphatase activity of calcineurin in a dose-dependent manner. Incubation of purified calcineurin with the antioxidants ascorbate, ascorbate 2-phosphate, alpha-lipoic acid, N-acetyl-L-cysteine and glutathione increased phosphatase activity relative to untreated controls. In contrast, several other commonly used antioxidants, including butylated hydroxytoluene, butylated hydroxyanisole, TEMPOL (4-hydroxy-2,2,6, 6-tetramethylpiperidine-N-oxyl), Trolox (6-hydroxy-2,5,7, 8-tetramethyl-chroman-2-carboxylic acid) and dihydrolipoic acid decreased the activity of purified calcineurin, possibly through prooxidative mechanisms. Although the antioxidant pyrrolidine dithiocarbamate increased the activity of purified calcineurin, it significantly inhibited the activity of calcineurin present in crude fibroblast lysates. These results support and extend the hypothesis that redox factors modulate the phosphatase activity of calcineurin and suggest that further in vivo studies are warranted.
Subject(s)
Antioxidants/pharmacology , Calcineurin/metabolism , Oxidants/pharmacology , Animals , Ascorbic Acid/pharmacology , Brain/enzymology , Butylated Hydroxyanisole/pharmacology , Butylated Hydroxytoluene/pharmacology , Cattle , Cell Line , Cyclic N-Oxides/pharmacology , Deferoxamine/pharmacology , Male , Mice , Paraquat/pharmacology , Peroxides/pharmacology , Pyrrolidines/pharmacology , Spin Labels , Sulfhydryl Compounds/pharmacology , Superoxides/pharmacology , Testis/enzymology , Thiocarbamates/pharmacology , Thioctic Acid/pharmacologyABSTRACT
In this study we tested the hypothesis that pyrethroid insecticides inhibit calcineurin directly and that inhibition is unaffected by the immunophilin cofactors necessary for calcineurin inhibition by cyclosporin A and FK506. The type II pyrethroid insecticides cis-cypermethrin (c-Cyp), trans-cypermethrin, deltamethrin (Delt), and fenvalerate A alpha (Fen), as well as the type I pyrethroid insecticides cis- and trans-permethrin and S-bioallethrin, were unable to inhibit the phosphatase activity of purified calcineurin under conditions of maximal activation by Ca2+ and calmodulin. Furthermore, c-Cyp, Delt, and Fen did not affect the Ca2+ dependence of calcineurin at 0.1 microM of calmodulin, indicating that Ca2+ binding to calmodulin was not affected by these agents. c-Cyp, Delt, and Fen also failed to inhibit calcineurin phosphatase activity in rat brain supernatant and cultured IMR-32 cells, although potent inhibition was displayed by both cyclosporin A and FK506 in each of these systems. Neither the Ca2+-dependent nor the okadaic acid-inhibitable phosphatase activity toward a 24-amino acid 32P-phospho-peptide substrate was affected by any of the pyrethroid insecticides, indicating that neither type-1 or type-2A phosphatase nor calcineurin is inhibited by pyrethroids. To determine if these results were dependent upon experimental conditions, experiments were repeated using polyethylene glycol-treated glass tubes in place of the standard polypropylene tubes. Regardless of the type of tube, no inhibition of calcineurin by any of the pyrethroid insecticides was observed. These data indicate that the pyrethroid insecticides are not effective inhibitors of calcineurin or other phosphatases.
Subject(s)
Brain/drug effects , Brain/metabolism , Calcineurin Inhibitors , Insecticides/pharmacology , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Pyrethrins/pharmacology , Animals , Brain/cytology , Calcium/metabolism , Calmodulin/metabolism , Cattle , Cells, Cultured/drug effects , Cells, Cultured/metabolism , RatsABSTRACT
Cyclosporin A (CsA) is a widely-used immunosuppressant drug whose therapeutic and toxic actions are mediated through inhibition of calcineurin (CN), a calcium- and calmodulin-dependent phosphatase. Inhibition of CN by CsA requires drug binding to its protein cofactor in the inhibition, cyclophilin. Because cyclophilin is a high affinity target for CsA it is expected that this protein can act as a reservoir for the drug in the cell and may be able to inhibit cellular efflux of CsA. P-glycoprotein (P-gp) is known to increase the rate of CsA efflux from CsA loaded cells but it is not clear if the P-gp drug efflux pump can compete effectively with cyclophilin at therapeutically relevant concentrations of CsA. To test the hypothesis that increased expression of P-gp confers protection against CsA-dependent inhibition of CN phosphatase activity, KB-V cells expressing varying levels of P-gp were analyzed to determine the potency of CsA as a CN inhibitor. When intact cells were treated with CsA, a positive correlation was observed between P-gp expression and resistance to CsA-dependent inhibition of CN: the IC50 is approximately 20-fold higher in the multidrug resistant epidermal carcinoma cell line, KB-V, which expresses P-gp at a high level than in the parental, KB, cell line expressing very low levels of P-gp. The resistance displayed by KB-V cells is abrogated by co-administration of the P-gp inhibitor verapamil, whereas verapamil has no effect on CsA potency in control KB cells. In cell lysates from KB-V cells with different amounts of P-gp CsA exhibits equivalent potency, indicating that the difference in sensitivity to CsA among the cell types requires maintenance of cell integrity. These observations support the view that resistance to CN inhibition by CsA occurs in cells with moderately elevated P-gp activity. Therefore, P-gp activity appears to be an important determinant of CsA cellular specificity for both therapeutic and toxic effects.
Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , Calcineurin Inhibitors , Cyclosporine/pharmacology , Immunosuppressive Agents/pharmacology , Amino Acid Sequence , Antineoplastic Agents, Phytogenic/pharmacology , Calcium Channel Blockers/pharmacology , Humans , KB Cells , Molecular Sequence Data , Verapamil/pharmacology , Vinblastine/pharmacologyABSTRACT
The aims of this investigation were to use a full-field thermoelastic technique to study the stress distribution on human teeth subjected to dynamic loads and derive a value for the thermoelastic constant for human enamel. Surface stresses were observed on extracted intact human molar teeth subjected to a load of 200 N cycled at 20 Hz. Measurements were repeated for the same teeth following mesio-occluso-distal cavity preparation and restoration with amalgam and adhesively bonded composite restorations. A value for the thermoelastic constant for human enamel (Km) of 2.25 X 10(-12)m2/N was calculated from physical coefficients in the literature. Unprepared specimens exhibited a comparable magnitude and distribution of stresses to those seen when teeth were restored with adhesively bonded composite restorations. Higher stresses were observed on prepared teeth and there was little change following restoration with amalgam. It can be concluded that a full-field thermoelastic stress analysis technique can be successfully applied to study teeth subjected to axial dynamic loads in vitro and that the resultant stresses are greater in prepared teeth than those restored with bonded composite materials.
Subject(s)
Dental Enamel/physiology , Acid Etching, Dental , Adhesives , Algorithms , Composite Resins , Dental Amalgam , Dental Bonding , Dental Cavity Preparation/classification , Dental Cavity Preparation/methods , Dental Restoration, Permanent/methods , Dental Stress Analysis/instrumentation , Dentin-Bonding Agents , Elasticity , Humans , Molar , Stress, Mechanical , ThermodynamicsABSTRACT
Conventional quasi-static and dynamic test methods have a number of limitations when used to measure the mechanical properties of enamel and dentine. These are due to the complex structure of the material and the small specimen size. In this investigation, a microindentation technique was used to measure the hardness and Young's modulus of human enamel and dentine and any variations with location. Freshly extracted molar teeth were sectioned, and the cut surfaces were ground and polished progressively to 1 micron. The polished surfaces were indented at different distances from the surface and amelodentinal junction with a Knoop indentor. Measurements of the length of the long indentation diagonal were used to calculate a value for hardness. It has been shown that the a-value for Young's modulus of a material can be calculated by comparing the ratio of the long and short diagonals on an indented specimen with the actual ratio of the indentor as any changes will be due to elastic recovery in the specimen. Values obtained for the Knoop hardness of enamel and dentine were in good agreement with those of other workers. It was also possible to show that there was a decrease in hardness with depth from the surface in enamel. The hardness of dentine increased with distance from the amelodentinal junction. Values for Young's modulus for dentine were in good agreement with those of other workers, and there was an increase in modulus with depth from the amelodentinal junction from 8.7 to 11.2 GNm-2. Values for Young's modulus of enamel were not as easy to calculate because of surface- and subsurface damage.
Subject(s)
Dental Enamel/physiology , Dentin/physiology , Confidence Intervals , Dental Enamel/ultrastructure , Dental Stress Analysis/instrumentation , Dental Stress Analysis/methods , Dentin/ultrastructure , Elasticity , Hardness , Humans , Molar , Stress, MechanicalABSTRACT
Epidemiological, experimental and clinical data indicate that cadmium and lead are osteotoxins in man and other species. The relative sensitivities of a clonal human osteosarcoma cell line (HOS TE 85) and a clonal rat osteosarcoma cell line (ROS 17.28) to the cytotoxic effects of cadmium and lead were tested in serum-free media without added growth factors. The rat osteosarcoma cells were more sensitive to cadmium with cytotoxicity and inhibition of proliferation at 0.25 versus 0.75 and 1.0 mumol l-1 cadmium, respectively, for human osteosarcoma cell lines. The lower sensitivity to cadmium of human osteosarcoma cells is attributed, at least partly, to induction of metallothionein synthesis by cadmium and zinc in this cell line; in the rat osteosarcoma cell line, they do not induce metallothionein synthesis. Human osteosarcoma cells were more sensitive than rat osteosarcoma cells to lead with inhibition (IC50) of proliferation at 4 mumol l-1 lead and cytotoxicity at 20 versus 6 and over 20 mumol l-1 lead, respectively, for these variables in rat osteosarcoma cells. Both cell lines attained the highest lead concentration in the 15,000 x g (mitochondrial) fraction. The lead in the mitochondrial, microsomal, nuclear and cytosolic fractions of the human cell line did not decrease during 24 h post-washout. Binding of lead was much less stable in the less sensitive rat cells, with 50-100% loss of mitochondrial, microsomal and nuclear lead during 24 h post-washout.
Subject(s)
Bone and Bones/drug effects , Cadmium/toxicity , Lead/toxicity , Metallothionein/biosynthesis , Mitochondria/drug effects , Animals , Bone and Bones/cytology , Bone and Bones/metabolism , Cell Division/drug effects , Humans , Mitochondria/metabolism , Osteosarcoma , Rats , Subcellular Fractions/chemistry , Tumor Cells, CulturedABSTRACT
Laboratory wear testing of ultra high molecular weight polyethylene from 12 Charnley acetabular cups, removed after periods of up to 17.5 years showed that the large patient-to-patient variations in clinical penetration rate cannot be explained by batch-to-batch variation in the wear resistance of the material. Nor was there any evidence of a time-dependent degradation in wear resistance of the material.
Subject(s)
Acetabulum , Hip Prosthesis , Materials Testing , Polyethylenes , Biocompatible Materials , Biodegradation, Environmental , Humans , Prosthesis FailureABSTRACT
ROS 17/2.8 cells, a cloned rat osteosarcoma cell line, are exceptionally sensitive to the cytotoxic effects of cadmium. This sensitivity is associated with the inability of this metal to induce the synthesis of metallothionein, a transition metal-binding protein, which detoxifies this metal by its sequestration. Sodium butyrate induces the synthesis of metallothionein in these cells in a concentration-dependent manner. Treatment with this agent also significantly increases the resistance of these cells to the cytotoxic effects of cadmium and the protective effect of butyrate is reversed upon its removal from culture medium. Butyrate treatment did not significantly alter the accumulation of cadmium by these cells. Hence, the increased synthesis of metallothionein in butyrate-treated cells is not due to increased cellular uptake of cadmium. Inhibition of DNA synthesis due to butyrate was not a sufficient condition to alter metallothionein synthesis or to protect against Cd-induced cytotoxicity. Equivalent inhibition of DNA synthesis with hydroxyurea failed to increase metallothionein synthesis in cadmium-treated cells. These results indicate that modulation of metallothionein gene expression in this cell line is the critical factor in determining cellular sensitivity to the cytotoxic effects of cadmium.
Subject(s)
Butyrates/pharmacology , Cadmium/toxicity , Metallothionein/biosynthesis , Osteosarcoma/metabolism , Animals , Butyric Acid , Cadmium/antagonists & inhibitors , Cell Line , Cell Survival/drug effects , Cells, Cultured , DNA, Neoplasm/biosynthesis , Metallothionein/isolation & purification , RatsABSTRACT
ROS 17/2.8 cells, a cloned rat osteoblastic osteosarcoma cell line, were found to be extremely sensitive to the lethal effects of cadmium and to synthesize little, if any, metallothionein in response to cadmium exposure. Culture of cells for 24 h in the presence of 1 microM 5-azacytidine, a cytidine analog, increased the inducibility of metallothionein by cadmium and significantly reduced (P less than 0.001) cytotoxicity. Anion exchange chromatographic analysis of cadmium binding to low molecular mass cytotoxicity. Anion exchange chromatographic analysis of cadmium binding to low molecular mass cytosolic proteins showed that cells treated with cadmium and 5-azacytidine expressed at least 2 isoforms of metallothionein. One isoform of metallothionein with a low affinity for cadmium was constitutively expressed by these cells. The association of poor inducibility of metallothionein by cadmium with extreme sensitivity of cells to cadmium emphasizes the role of this protein in the cellular response to this toxic metal. The modulation of metallothionein inducibility and sensitivity to cadmium by 5-azacytidine treatment suggest that metallothionein gene structure and regulation are altered in ROS 17/2.8 cells.
Subject(s)
Azacitidine/pharmacology , Cadmium/toxicity , Metallothionein/biosynthesis , Osteosarcoma/enzymology , Animals , Cadmium/metabolism , Chromatography, DEAE-Cellulose , Chromatography, Gel , Enzyme Induction , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Metallothionein/genetics , Osteosarcoma/metabolism , Rats , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/enzymologyABSTRACT
Frozen tissue immunoreactivity with Ki-67, a monoclonal antibody that recognizes a nuclear antigen in nonresting or proliferating cells, was compared to DNA flow cytometry results (from fresh tissue) in a diverse group of 60 soft-tissue lesions. Both DNA index and Ki-67 score were independently reported to be associated with grade and prognosis in sarcomas, but no direct comparison of these two variables was made. It was attempted to measure proliferative activity in fixed paraffin-embedded tissues immunohistochemically in a subset of lesions using an antibody to another nuclear proliferation antigen, p105. Lesions were given a grade according to lesion category (reactive, 1; benign, 2; low-grade malignant, 3; and high-grade malignant, 4). Ki-67 reactivity correlated relatively well with this grading system (r = 0.59); benign lesions usually exhibited a low Ki-67 score and malignant lesions usually but not always exhibited a high score. For example, some malignant fibrous histiocytomas contained only rare positive cells. Some disparity between Ki-67 score and grade and within histologic types indicates some independence from these features, a fact that may be important when correlation with prognosis is performed. However Ki-67 did not correlate well with flow data such as percentage S phase (r = 0.30), percentage S + G2M phases (r = 0.37), or DNA index (r = 0.39). This probably is due to the fact that Ki-67 also marks cells in the G1 phase, whereas these are excluded in flow data analyses. Anti-p105 highlighted almost all nuclei in all cases tested, including fibromatosis, and did not correlate with Ki-67 score, histologic grade or DNA flow cytometric data. Results with p105 could not be favorably affected by titration experiments. It is reasonable to conclude that the Ki-67 score is a variable related to but independent of histologic grade, histologic type, and DNA flow values. Whether it is prognostically important in human sarcomas, as has been suggested, awaits further clinicopathologic study.